Brief: Cryofocus Medtech Shanghai Co Says Grant Of Listing Approval
04/04/2024 02:28
April 4 (Reuters) - Cryofocus Medtech Shanghai Co Ltd
6922.HK :
* GRANT OF LISTING APPROVAL BY STOCK EXCHANGE FOR
IMPLEMENTATION
OF H SHARE FULL CIRCULATION
* CONVERSION & LISTING WILL INVOLVE 29.3 MILLION UNLISTED
SHARES
HELD BY 8 PARTICIPATING SHAREHOLDERS
Further company coverage: 6922.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cryofocus Medtech (Shanghai) Co
See all newsBrief: Cryofocus Medtech (Shanghai) To Allot & Issue 7.5 Million H Shares
Brief: Cryofocus Medtech (Shanghai) Says Anti-Gastroesophageal Reflux System Granted Approval By Nmpa
Brief: Cryofocus Medtech Shanghai Says China's NMPA Approves Registration Change Of Disposable Cryoprobe Of Cryoadhesion System
Brief: Cryofocus Medtech Shanghai Says US' FDA Grants Breakthrough Device Designation For Asthma Cryoablation System
Brief: Cryofocus Medtech Shanghai Receives NMPA Approval For Malignant Stenosis Cryoablation System